BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9262991)

  • 1. Expansion of polyclonal B-cell precursors in bone marrow from children treated for acute lymphoblastic leukemia.
    Duval M; Fenneteau O; Cave H; Gobillot C; Rohrlich P; Guidal C; Lescoeur B; Legac S; Schlegel N; Sterkers G; Vilmer E
    Hematol Cell Ther; 1997 Jun; 39(3):139-47. PubMed ID: 9262991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell precursor bone marrow reconstitution after bone marrow transplantation.
    Leitenberg D; Rappeport JM; Smith BR
    Am J Clin Pathol; 1994 Aug; 102(2):231-6. PubMed ID: 8042594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study Group.
    Brisco MJ; Condon J; Hughes E; Neoh SH; Nicholson I; Sykes PJ; Tauro G; Ekert H; Waters K; Toogood I
    Leukemia; 1993 Oct; 7(10):1514-20. PubMed ID: 8412313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of leukemic clone-specific immunoglobulin heavy chain rearrangements in neonatal blood spots of children with B-cell precursor acute lymphoblastic leukemia.
    Kacanski N; Kolarovic J; Kostic T; Marjanovic I; Janic D; Pavlovic S; Karan-Djurasevic T
    Int J Lab Hematol; 2024 Apr; 46(2):303-311. PubMed ID: 37929321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease.
    van Wering ER; van der Linden-Schrever BE; Szczepański T; Willemse MJ; Baars EA; van Wijngaarde-Schmitz HM; Kamps WA; van Dongen JJ
    Br J Haematol; 2000 Jul; 110(1):139-46. PubMed ID: 10930991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of immunoglobulin and T-cell receptor-δ/γ gene rearrangements in Iranian children with B-precursor acute lymphoblastic leukemia.
    Poopak B; Saki N; Purfatholah AA; Najmabadi H; Mortazavi Y; Arzanian MT; Khosravipour G; Haghnejad F; Salari F; Shahjahani M
    Hematology; 2014 Jul; 19(5):259-66. PubMed ID: 24620952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttherapy surveillance of B-cell precursor acute lymphoblastic leukemia. Value of polymerase chain reaction and limitations of flow cytometry.
    Kallakury BV; Hartmann DP; Cossman J; Gootenberg JE; Bagg A
    Am J Clin Pathol; 1999 Jun; 111(6):759-66. PubMed ID: 10361511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of immunoglobulin heavy chain variable gene repertoires and highly selective detection of malignant clonotypes in acute lymphoblastic leukemia.
    Greenberg SJ; Choi Y; Ballow M; Du TL; Ward PM; Rickert MH; Frankel S; Bernstein SH; Brecher ML
    J Leukoc Biol; 1995 Jun; 57(6):856-64. PubMed ID: 7790768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia.
    Umiel T; Pattengale P; Weinberg K
    Leukemia; 1993 Mar; 7(3):435-40. PubMed ID: 8445948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
    Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
    N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
    Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
    Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood].
    Baersch G; Baumann M; Meltzer J; Möllers T; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1996; 208(4):160-7. PubMed ID: 8926682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicolor flow-cytometric, morphologic, and clonogenic analysis of marrow CD10-positive cells in children with leukemia in remission or nonmalignant diseases.
    Fukushima T; Sumazaki R; Koike K; Tsuchida M; Matsui A; Nakauchi H
    J Pediatr Hematol Oncol; 1998; 20(3):222-8. PubMed ID: 9628433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal evolution as judged by immunoglobulin heavy chain gene rearrangements in relapsing precursor-B acute lymphoblastic leukemia.
    Rosenquist R; Thunberg U; Li AH; Forestier E; Lönnerholm G; Lindh J; Sundström C; Sällström J; Holmberg D; Roos G
    Eur J Haematol; 1999 Sep; 63(3):171-9. PubMed ID: 10485272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual disease detection in multiple follow-up samples in children with acute lymphoblastic leukemia.
    Kitchingman GR
    Leukemia; 1994 Mar; 8(3):395-401. PubMed ID: 8127144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a human pro-B cell line (JKB-1) and its differentiation of preestablished bone marrow stromal cell layer.
    Urashima M; Hasegawa N; Kamijo M; Shishikura A; Kato Y; Hoshi Y; Akatsuka J; Maekawa K
    Am J Hematol; 1994 Jun; 46(2):112-9. PubMed ID: 8172177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis.
    Beishuizen A; Verhoeven MA; Hählen K; van Wering ER; van Dongen JJ
    Leukemia; 1993 Jun; 7(6):60-3. PubMed ID: 8315958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.